Improved Quality of LIfe for Lung-Cancer Patients

African-American and older patients with advanced lung cancer can be effectively treated with a new, federally approved therapy, according to researchers from the University of Cincinnati. Such patients are not good candidates for chemotherapy.

The findings were published in the journal Libertas Academica.

The treatment the researchers focused on is gefitinib, a drug that’s already used to treat other kinds of cancer. The study looked at the effect of the drug on patients with non-small cell lung cancer, which does not have many treatment options.

Stuff the Turkey, Not Yourself: 10 Stay-Slim Tips for Thanksgiving

By Justine SanFilippo, MS, CHC

National Family Health History Day

Happy Thanksgiving from all of us here at ThirdAge to you and yours! Each year since 2004, the Surgeon General has declared Thanksgiving to be National Family Health History Day. Over the holiday or at other times when families gather, the Surgeon General encourages Americans to talk about, and to write down, the health problems that seem to run in their family. Learning about their family's health history may help ensure a longer, healthier future together.

Breakthrough in Understanding Parkinson's Disease

Scientists at Trinity College Dublin have made an important breakthrough in the understanding of Parkin, a protein that regulates the repair and replacement of nerve cells within the brain. The discovery generates a new perspective on how nerve cells die in Parkinson's disease. The Trinity research group, led by Seamus Martin,Smurfit Professor of Medical Genetics, published its findings in November 2014 in Cell Reports.

Better Drugs for Diabetes?

New research has found that a crucial signaling pathway, already implicated in the development of cancer, is also linked to the development of type 2 diabetes.

Increased knowledge of the MEK/ERK pathwaycould pave the way for more effective treatment of diabetes.

The study, by researchers from Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, also shed additional light on how a class of diabetes drugs, known as thiazolidinediones (TZDs), work to improve glucose metabolism.


About Us

For over a decade, ThirdAge has been a leading source of information for "boomer and beyond" women. Our writers cover what means most to women 50+: the empty nest, living solo, finding love, coping with caregiving, and remaking their lives the way they want them to be. We also feature the latest approaches to brain fitness, diet, exercise, and age-related health conditions.